Veronika von Messling


Country: Germany


  1. Walz L, Kays S, Zimmer G, von Messling V. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype. J Virol. 2018;92: pubmed publisher
    ..Such vaccines may also provide partial protection against newly emerging strains with the same NA but a different HA subtype. ..
  2. Enkirch T, von Messling V. Ferret models of viral pathogenesis. Virology. 2015;479-480:259-70 pubmed publisher
    ..To provide decision criteria for the use of this animal model, its strengths and limitations will be discussed. ..
  3. Pfeffermann K, Dörr M, Zirkel F, von Messling V. Morbillivirus Pathogenesis and Virus-Host Interactions. Adv Virus Res. 2018;100:75-98 pubmed publisher
    ..It also summarizes the state of knowledge regarding virus-host interactions on the cellular level with an emphasis on viral interference with innate immune response activation, and highlights remaining knowledge gaps. ..
  4. Schmidt R, Holznagel E, Neumann B, Alex N, Sawatsky B, Enkirch T, et al. Squalene-containing licensed adjuvants enhance strain-specific antibody responses against the influenza hemagglutinin and induce subtype-specific antibodies against the neuraminidase. Vaccine. 2016;34:5329-5335 pubmed publisher
  5. da Fontoura Budaszewski R, von Messling V. Morbillivirus Experimental Animal Models: Measles Virus Pathogenesis Insights from Canine Distemper Virus. Viruses. 2016;8: pubmed
    ..It then summarizes the contributions made by studies on the CDV in dogs and ferrets to our understanding of MeV pathogenesis and to vaccine and drugs development. ..
  6. Delpeut S, Sawatsky B, Wong X, Frenzke M, Cattaneo R, von Messling V. Nectin-4 Interactions Govern Measles Virus Virulence in a New Model of Pathogenesis, the Squirrel Monkey (Saimiri sciureus). J Virol. 2017;91: pubmed publisher